World Muscle Society Congress 2026 (WMS)

Back

FORZETTO, a Phase 3 Study of Zeleciment Rostudirsen in Ambulatory Males with DMD Mutations Amenable to Exon 51 Skipping (poster)

HARMONIA Study Design: A Global Phase 3 Trial Assessing the Efficacy and Safety of Zeleciment Basivarsen in DM1 (poster)

Long-Term Functional Improvement With Zeleciment Basivarsen in the Phase 1/2 ACHIEVE Trial (presentation)

Long-Term Functional Improvement With Zeleciment Basivarsen in the Phase 1/2 ACHIEVE Trial (supplemental data)

Zeleciment Rostudirsen Increased Dystrophin Protein Levels and Led to Functional Improvement in Clinical Measures in the DELIVER Trial (poster)

Zeleciment Rostudirsen Increased Dystrophin Protein Levels and Led to Functional Improvement in Clinical Measures in the DELIVER Trial (supplemental data)